GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Precipio Inc.
Precipio is a cancer diagnostics company. Its stock price reflects its struggle to commercialize its products and services. Its price is volatile and dependent on sales and partnership news.
Share prices of companies in the market segment - Cancer analysis
Precipio, Inc. is a diagnostics company that develops and markets technologies and tests for accurate cancer diagnosis. We've categorized it as a "Cancer Analysis" company. The chart below shows how the market values companies improving cancer diagnosis and personalized treatment.
Broad Market Index - GURU.Markets
Precipio is a diagnostic company that develops and markets tests and technologies for cancer detection and characterization. Its innovation has earned it a spot in the GURU.Markets index. The chart below compares its performance with the overall market.
Change in the price of a company, segment, and market as a whole per day
PRPO - Daily change in the company's share price Precipio Inc.
For Precipio, Inc., a cancer diagnostics company, daily volatility reflects sensitivity to the adoption of its tests in hospitals. This metric is an indicator of demand for innovative oncology solutions, serving as a basis for analysis.
Daily change in the price of a set of shares in a market segment - Cancer analysis
Precipio, Inc. is a cancer diagnostics company. This chart highlights the high volatility of the healthcare sector. Comparing it to PRPO, whose business depends on the adoption of its tests, helps assess it as a barometer of the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Precipio specializes in cancer diagnostics, providing technologies for more accurate analysis. The company's shares react to news of its tests being adopted by the medical community. This specific volatility, driven by medical innovation, feeds into the overall market movement.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Precipio Inc.
Precipio, Inc.'s year-over-year performance is a story of commercialization of its diagnostic technologies. Its 12-month market capitalization growth reflects increased sales of its blood cancer detection kits and IV-Cell technology, which significantly reduces the time required to obtain cytogenetic analysis results—its key advantage.
Annual dynamics of market capitalization of the market segment - Cancer analysis
Precipio, Inc. is a cancer diagnostics company focused on commercializing its innovative tests. This chart shows how its struggle for market share, reimbursement system dependence, and competition are impacting its volatile performance in the biotech sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Precipio, specializing in cancer diagnostics, operates in the defensive healthcare sector. Demand for cancer tests is unaffected by economic cycles. The company's stock price reflects the long-term trend toward personalized medicine and early detection.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Precipio Inc.
Precipio is a company specializing in oncology diagnostics. Its monthly growth reflects growing sales of its products and services, particularly its ICE COLD-PCR technology. Quarterly revenue reports and laboratory partnerships are key drivers of its growth.
Monthly dynamics of market capitalization of the market segment - Cancer analysis
Precipio, Inc. develops and markets diagnostic products and services in oncology. Its goal is to make accurate cancer diagnosis more accessible. The medical diagnostics sector is growing thanks to personalized medicine. Against this backdrop, Precipio aims to carve out a niche by offering technologies that help doctors make faster and more accurate diagnoses.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Precipio, Inc. is a diagnostic company focused on combating cancer misdiagnosis. Its business consists of providing technologies and services to improve diagnostic accuracy. The broader market graph illustrates the relevance of its unique mission and innovative products, such as the HemeScreen platform, to the medical community.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Precipio Inc.
Precipio is a cancer diagnostics company. Its weekly stock price is driven by sales of its diagnostic tests and products, as well as news about the implementation of its technologies in clinical laboratories and hospitals.
Weekly dynamics of market capitalization of the market segment - Cancer analysis
Precipio is a cancer diagnostics company. Its weekly stock price is driven by sales of its diagnostic tests and products, as well as news about the implementation of its technologies in clinical laboratories and hospitals.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Precipio, a diagnostics company, lives in a world of its own. Its performance is driven by sales and partnership news. A comparison chart with the S&P 500 clearly demonstrates how the stock can move regardless of the broader market.
Market capitalization of the company, segment and market as a whole
PRPO - Market capitalization of the company Precipio Inc.
Precipio's market capitalization tells the story of a company developing oncology diagnostic technologies. Its chart reflects its struggle to commercialize its products and gain market acceptance. It's a visualization of how difficult it is for a small diagnostics company to compete with the giants.
PRPO - Share of the company's market capitalization Precipio Inc. within the market segment - Cancer analysis
Precipio is a cancer diagnostics company providing technology and services for laboratories. Its market share reflects its position in the segment. The chart below shows how investors value its patented technologies and their potential to improve diagnostic accuracy.
Market capitalization of the market segment - Cancer analysis
Precipio is a diagnostics company focused on developing oncology tests. The chart below shows the overall market capitalization of the cancer testing sector. It reflects the importance of accurate diagnostics for choosing the right treatment and the growing role of new technologies in this field.
Market capitalization of all companies included in a broad market index - GURU.Markets
This shows diagnostics that improve testing. Precipio develops technologies that improve the accuracy of cancer diagnostics. Its line on the graph reflects its ability to sell these technologies to hospitals and labs, improving patient outcomes.
Book value capitalization of the company, segment and market as a whole
PRPO - Book value capitalization of the company Precipio Inc.
Precipio's foundation is its cancer diagnostic technologies and laboratories, including its liquid biopsy platform. Its book value reflects this advanced diagnostic capital. The chart shows how the company is building its foundation for commercializing its tests, which are designed to make cancer diagnostics more accurate and accessible.
PRPO - Share of the company's book capitalization Precipio Inc. within the market segment - Cancer analysis
Precipio is a diagnostics company providing cancer detection technologies. Its assets are certified laboratories. The chart shows the share of physical laboratory infrastructure for cancer diagnostics the company controls.
Market segment balance sheet capitalization - Cancer analysis
Oncology diagnostics, as the BCap_Ges chart shows, is a knowledge-intensive business. Precipio, Inc., which provides diagnostic products and services, relies on its laboratories and R&D. Its assets are scientific infrastructure, not giant factories.
Book value of all companies included in the broad market index - GURU.Markets
Precipio's assets are certified laboratories equipped with expensive diagnostic equipment. Their book value is the valuation of this physical infrastructure, which enables the company to conduct complex analyses and tests, aiding in the diagnosis and treatment of cancer.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Precipio Inc.
Precipio has developed a technology to improve cancer diagnostics. It's a MedTech company, with its value coming from its patents. Its book value is low. Its market capitalization is an estimate of how well its technology will be adopted by labs and hospitals. The MvsBCap chart will reflect the success of its tests' commercialization and adoption.
Market to book capitalization ratio in a market segment - Cancer analysis
Precipio provides diagnostic products and services in oncology. Its value lies in its technologies that help detect cancer. The chart shows how the market values its innovative diagnostic solutions.
Market to book capitalization ratio for the market as a whole
Precipio has developed technology for more accurate cancer diagnosis. Its value lies in its diagnostic platforms and tests. Its market valuation reflects the potential of its technology to improve diagnostic standards and become an integral part of oncology treatment. The graph shows the diagnostic innovation award.
Debts of the company, segment and market as a whole
PRPO - Company debts Precipio Inc.
Precipio, a company providing diagnostic products and services in oncology, uses capital for R&D, marketing, and laboratory expansion. Bringing new diagnostic tests to market is an expensive process. This chart shows how the company funds its mission to improve cancer diagnostics by making cutting-edge technologies more accessible.
Market segment debts - Cancer analysis
Precipio, Inc. provides diagnostic products and services for oncology. In the medical diagnostics sector, precision and innovation are essential. Its debt policy may reflect investments in the development of new tests or the expansion of laboratory capacity. The chart shows how Precipio funds its mission to improve cancer diagnostics.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Precipio Inc.
Precipio develops diagnostic tests for oncology, striving to make them more accurate and accessible. This chart shows how the company funds its research and commercialization. Its reliance on debt could become a risk if its tests fail to gain widespread acceptance among doctors or insurance companies refuse to cover them.
Market segment debt to market segment book capitalization - Cancer analysis
Precipio provides diagnostic products and services for oncology. The chart shows the overall debt burden in the sector. It helps assess how the company is funding the commercialization of its technologies, striving to make cancer diagnostics more accurate and accessible, and how its financial structure compares to other players in the medical diagnostics market.
Debt to book value of all companies in the market
Precipio, Inc. provides diagnostic products and services that help detect cancer. For a company in the medical diagnostics sector, the overall financial situation, as reflected in the chart, is important. It impacts hospital and laboratory budgets, as well as patient solvency and insurance coverage, which determines demand for diagnostic tests.
P/E of the company, segment and market as a whole
P/E - Precipio Inc.
This chart from Precipio, Inc., a company providing oncology diagnostic solutions, shows how investors value its technologies. The dynamics reflect expectations for demand for its tests, which help doctors make more accurate diagnoses and tailor treatments, a key aspect of modern medicine.
P/E of the market segment - Cancer analysis
This chart shows the average P/E for the medical diagnostics sector, where Precipio offers its solutions. The industry's high valuation reflects a belief in personalized medicine. This metric helps understand how the market values Precipio's technology relative to other diagnostics companies.
P/E of the market as a whole
Precipio develops diagnostic tests and reagents for oncology. Its goal is to make cancer diagnosis more accurate and accessible. The company's success depends on the implementation of its tests in clinical practice. This chart shows the mood in the medtech sector. It helps understand how the market views Precipio's technology and its ability to compete with major diagnostic companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Precipio Inc.
Precipio, Inc. provides diagnostic products and services that help detect and characterize cancer. The company's growth depends on the adoption of its technologies in oncology laboratories. This chart reflects analyst expectations regarding demand for innovative cancer diagnostic methods and the commercial success of the company's products.
%20P%2FE%20Precipio%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Precipio-Inc.&v=1772554023461 "Chart of the company's future (projected) P/E Precipio Inc.")
Future (projected) P/E of the market segment - Cancer analysis
Precipio provides diagnostic products and services that help oncologists make more accurate diagnoses. This chart shows how the company's future revenue expectations compare to the industry average. Does the market view its technology as a valuable tool in the fight against cancer?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Cancer-analysis&v=1772554023473 "Future (projected) P/E graph of the market segment - Cancer analysis")
Future (projected) P/E of the market as a whole
Precipio, Inc. provides diagnostic products and services for oncology. Demand for its products is driven by the needs of the healthcare system. The company's valuation, however, depends on sentiment in the biotech sector, which correlates with this chart. During periods of optimism, investors assign higher valuations to companies working in the field of cancer diagnostics.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772554023522 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Precipio Inc.
Precipio, Inc. provides diagnostic products and services that help detect cancer. The company's revenue depends on the number of tests processed in its lab and the sales of its diagnostic kits. This chart shows how innovations in cancer diagnostics and the pursuit of personalized medicine are driving demand for its technologies.
Profit of companies in the market segment - Cancer analysis
Precipio provides diagnostic products and services for oncology. Its ICE COLD-PCR technology enables the detection of cancer mutations with high accuracy, which is essential for personalized medicine. This chart demonstrates the growing profitability of the oncology diagnostics sector, which is key to selecting the right targeted therapy and improving treatment outcomes.
Overall market profit
Precipio, Inc. provides diagnostic products and services in the oncology field. Demand for accurate cancer diagnostics is growing. However, the overall economic situation, reflected in this chart, is impacting the budgets of hospitals and laboratories, which are Precipio's primary customers.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Precipio Inc.
Precipio is a cancer diagnostics company offering technologies and services that help pathologists make more accurate diagnoses. This chart reflects analysts' expectations for the growth of the cancer diagnostics market and the company's ability to market its innovative products and services.
%20profit%20of%20the%20company%20Precipio%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Precipio-Inc.&v=1772554023816 "Graph of future (projected) profit of the company Precipio Inc.")
Future (predicted) profit of companies in the market segment - Cancer analysis
Precipio, Inc. provides diagnostic products and services for oncology. The company's technologies, such as ICE COLD-PCR™, enable the detection of cancer mutations with high sensitivity, which is essential for personalized medicine. This chart shows revenue projections for the healthcare sector, reflecting the growing demand for accurate and advanced cancer diagnostic methods.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Cancer-analysis&v=1772554023917 "Graph of future (predicted) profits of companies in a market segment - Cancer analysis")
Future (predicted) profit of the market as a whole
Precipio, Inc. provides diagnostic products and services, particularly in the field of oncology. Demand for medical diagnostics is stable, but the implementation of new, more expensive tests depends on laboratory and hospital budgets. This trend, reflecting the overall state of the economy, indirectly impacts the healthcare system's financial capacity for modernization.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772554023948 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Precipio Inc.
Precipio provides diagnostic products and services in oncology. This chart shows how the market values its revenue. The ratio reflects the acceptance of its diagnostic tests by the medical community and its role in improving cancer diagnostics.
P/S market segment - Cancer analysis
Precipio, Inc. is a cancer diagnostics company that provides reagents and services for pathology laboratories. This chart shows the average revenue estimate for the medical diagnostics sector. It helps understand how investors value Precipio's products, which are designed to improve the accuracy and accessibility of cancer diagnostics.
P/S of the market as a whole
Precipio provides oncology diagnostic products and services that help doctors make accurate diagnoses and tailor treatments. Their business is focused on improving precision in the fight against cancer. This chart shows the average market revenue estimate, helping to understand how investors value companies in the oncology diagnostics field.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Precipio Inc.
Precipio develops diagnostic tests and products for oncology that help detect cancer more accurately. This chart shows how the market estimates its future sales. This estimate depends on the adoption of its technologies by laboratories and hospitals, as well as its ability to commercialize its innovative diagnostic solutions.
%20P%2FS%20Precipio%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Precipio-Inc.&v=1772554024214 "The graph of the company's future (projected) P/S Precipio Inc.")
Future (projected) P/S of the market segment - Cancer analysis
Precipio is a cancer diagnostics company. It provides technologies and services that help pathologists make more accurate diagnoses, particularly for rare cancers. This chart shows how the market values its diagnostic products and services.
%20P%2FS%20market%20segment%20graph%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Cancer-analysis&v=1772554024343 "Future (projected) P/S market segment graph - Cancer analysis")
Future (projected) P/S of the market as a whole
Precipio is a cancer diagnostics company. It provides pathology services and develops diagnostic tests. This chart, reflecting expectations for rising healthcare costs, is important for Precipio. Economic growth allows the healthcare system to invest more in accurate and early cancer diagnosis, increasing demand for the company's services.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772554024486 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Precipio Inc.
Precipio, Inc. is a company specializing in cancer diagnostics. This chart shows revenue from providing diagnostic services to cancer centers and from sales of its unique technologies and reagents to laboratories. The growth here reflects the demand for more accurate and advanced cancer diagnostic methods.
Sales of companies in the market segment - Cancer analysis
Precipio, Inc. is a cancer diagnostics company. Its business is divided into two key segments: sales of diagnostic products and reagents (such as HemeScreen technology) and the provision of laboratory services to other healthcare providers. This chart shows revenue from one of these segments, reflecting its contribution to the fight against cancer.
Overall market sales
Precipio, Inc. develops diagnostic tests for oncology. Its technologies are aimed at increasing the accuracy and reducing the cost of cancer diagnostics. Demand for its products is driven by the healthcare system's need for more effective diagnostic methods that enable earlier treatment. This is an important part of the innovation economy in medicine.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Precipio Inc.
Precipio is a cancer diagnostics company providing technologies and services that help pathologists make more accurate diagnoses. Its revenue forecast is based on sales of its diagnostic products and services to hospitals and laboratories, reflecting the growing importance of accurate diagnostics in oncology.
%20sales%20of%20the%20company%20Precipio%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Precipio-Inc.&v=1772554024677 "Schedule of future (projected) sales of the company Precipio Inc.")
Future (projected) sales of companies in the market segment - Cancer analysis
Precipio, Inc. provides diagnostic products and services that help detect cancer. This chart reflects expectations for the entire cancer testing sector. It helps assess the growth of the cancer diagnostics market, the demand for accurate and rapid tests, and the rate of adoption of new technologies in laboratories, as analysts predict.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Cancer-analysis&v=1772554024733 "Schedule of future (projected) sales of companies in the market segment - Cancer analysis")
Future (projected) sales of the market as a whole
Precipio provides diagnostic products and services in oncology. Demand for its products depends on the volume of tests performed and laboratory budgets. This overall sales forecast chart reflects the state of the economy, which impacts healthcare spending and the adoption of new diagnostic methods.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772554024830 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Precipio Inc.
Precipio, Inc. provides diagnostic products and services that help detect cancer. The company strives to make accurate diagnostics more accessible. This chart shows how revenue from diagnostic tests and services compares to research, development, and laboratory operations costs, driving the company's bottom line.
Market segment marginality - Cancer analysis
Precipio is a company specializing in cancer diagnostics. They provide technologies and services that help pathologists make more accurate diagnoses. Profitability in this field depends on the accuracy of their tests and their ability to sell their solutions to hospitals and labs. The chart below illustrates the effectiveness of their business model.
Market marginality as a whole
Precipio, Inc. is a cancer diagnostics company. It offers technologies and services that help detect cancer more accurately. Profitability depends on the adoption of its tests in clinical practice. This chart shows overall profitability, but for PRPO, the growing importance of early and accurate cancer diagnosis is a key driver of its business.
Employees in the company, segment and market as a whole
Number of employees in the company Precipio Inc.
Precipio is a diagnostics company focused on oncology. This chart shows its team of pathologists, lab technicians, and sales specialists. This team's growth reflects increased testing volumes and the successful implementation of their diagnostic products in hospitals and labs.
Share of the company's employees Precipio Inc. within the market segment - Cancer analysis
Precipio, Inc. develops diagnostic technologies that aid in cancer treatment. Accurate and rapid diagnostics are key to successful treatment. This metric reflects its commitment to this critical area of oncology, where its technologies help doctors make the right decisions.
Number of employees in the market segment - Cancer analysis
Precipio, Inc. provides diagnostic products and services for oncology. This chart reflects employment in the cancer testing sector. The growing number of pathologists and laboratory technicians highlights the importance of accurate and rapid diagnostics for appropriate treatment selection. Precipio aims to improve this process with its technology.
Number of employees in the market as a whole
Precipio provides diagnostic products and services for oncology. The cancer diagnostics sector is growing as the population ages and personalized medicine advances. This trend provides the company with stable demand, less dependent on general economic cycles, as shown in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Precipio Inc. (PRPO)
Precipio, Inc. provides diagnostic products and services in oncology. In the field of medical diagnostics, both technology and qualified personnel are essential. The moderate capitalization per employee in this graph may reflect the balance between the cost of unique technologies and the need to maintain laboratories and specialists.
%20of%20the%20company%20Precipio%20Inc.%20(PRPO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Precipio-Inc.-PRPO&v=1772554025507 "Chart of market capitalization per employee (in thousands of dollars) of the company Precipio Inc. (PRPO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Cancer analysis
Precipio, Inc. provides diagnostic products and services that aid in cancer diagnosis. In the medical diagnostics sector, this metric reflects the value of their technologies and patents. How effective and valuable are their solutions for the healthcare system compared to their competitors?
%20by%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Cancer-analysis&v=1772554025585 "Market capitalization per employee (in thousands of dollars) by market segment - Cancer analysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Precipio, Inc. provides diagnostic products and services that help detect cancer. Their goal is to make accurate diagnostics more accessible. The chart shows the market valuation of this company operating in the critical field of oncology diagnostics.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772554025673 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Precipio Inc. (PRPO)
Precipio (PRPO) is a company specializing in cancer diagnostics. They provide services (pathology) and products (laboratory kits) to ensure more accurate diagnostics. This chart shows how effective their hybrid model (services + products) is. It measures how their team of pathologists and manufacturing staff generates revenue in the important diagnostics sector.
%20Chart%20Precipio%20Inc.%20(PRPO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Precipio-Inc.-PRPO&v=1772554025811 "Company Profit Per Employee (in thousands of dollars) Chart Precipio Inc. (PRPO)")
Profit per employee (in thousands of dollars) in the market segment - Cancer analysis
Precipio, Inc. is a cancer diagnostics company. They provide technologies and services that help make accurate diagnoses. In medical diagnostics, the efficiency and accuracy of the laboratory and team are crucial. This metric reflects how productive their business model is in creating value.
%20in%20the%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Cancer-analysis&v=1772554025836 "Chart of profit per employee (in thousands of dollars) in the market segment - Cancer analysis")
Profit per employee (in thousands of dollars) for the market as a whole
Precipio (PRPO) is a medical diagnostics company providing technology and services (for example, in oncology). It's a hybrid of MedTech and services. This chart shows how effectively their team (lab technicians, salespeople) generates revenue from sales of diagnostic kits and laboratory services.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772554025893 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Precipio Inc. (PRPO)
Precipio is a company specializing in cancer diagnostics. This chart shows how the company monetizes its diagnostic tests and technologies. The increase in revenue per employee reflects increased testing volumes and the adoption of its products by oncology clinics.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Precipio-Inc.-PRPO&v=1772554025991 "Sales chart per company employee Precipio Inc. (PRPO)")
Sales per employee in the market segment - Cancer analysis
Precipio (PRPO) is a company specializing in cancer diagnostics. They provide technology and services (including second opinions) to improve diagnostic accuracy. This chart compares Precipio's revenue per employee to the industry average, demonstrating the demand for their diagnostic services and products.
Sales per employee for the market as a whole
Precipio (PRPO) is a medtech company specializing in cancer diagnostics. They sell kits (HemeScreen) and provide services (IV-Cell) to labs to improve diagnostic accuracy. They operate as a hybrid of product and service sales. This chart shows the revenue generated by their lab and sales team.
Short shares by company, segment and market as a whole
Shares shorted by company Precipio Inc. (PRPO)
Precipio (PRPO) offers cancer diagnostic technologies (liquid biopsy). It's a hot, but also crowded, field. This chart shows the number of investors who doubt Precipio's technology is superior to that of dozens of other companies vying for this market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Precipio-Inc.-PRPO&v=1772554026208 "Short Shares Chart for the Company Precipio Inc. (PRPO)")
Shares shorted by market segment - Cancer analysis
Precipio (PRPO) is a company specializing in cancer diagnostics. They provide diagnostic services (second opinions) and sell technologies that help labs improve test accuracy. This chart shows the odds against the cancer diagnostics sector, reflecting concerns about competition and the difficulty of receiving reimbursement from insurance companies.
Shares shorted by the overall market
Precipio provides diagnostic solutions for oncology, striving to improve the accuracy of testing. This is an important mission, but the company is small and operates in a market dominated by giants. This chart measures the overall level of fear. When investors are pessimistic, they avoid microcaps. They fear that PRPOs will lack capital for R&D and marketing, and they sell off shares due to high risk and low liquidity.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Precipio Inc. (PRPO)
Precipio (PRPO) specializes in advanced diagnostic technologies for cancer detection, aiming to improve the accuracy of testing. Shares of such innovative companies are characterized by sharp price movements on news. This indicator measures the speed and strength of these price movements, helping to identify when investor enthusiasm (above 70) or disillusionment (below 30) reaches extremes.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Precipio-Inc.-PRPO&v=1772554026387 "RSI 14 indicator chart for the company's stock Precipio Inc. (PRPO)")
RSI 14 Market Segment - Cancer analysis
Precipio (PRPO) is at the forefront of the fight against cancer, developing diagnostic technologies (including liquid biopsy) that help doctors stay ahead of the disease. This chart shows the overall sentiment in the Cancer Testing sector. It helps investors distinguish Precipio's unique scientific breakthrough from the overall "overheated" or "oversold" sentiment in the oncology diagnostics industry.
RSI 14 for the overall market
For Precipio, a cancer diagnostics company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the cash spigot is turned off, and cash-burning companies risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PRPO (Precipio Inc.)
Precipio (PRPO) is a cancer diagnostics company. It provides expert pathology consulting services and sells its HemeScreen diagnostic kits. This chart shows the speculative average price target from analysts, based on their belief in growth in testing volumes and sales.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PRPO-Precipio-Inc.&v=1772554026621 "A chart showing analyst consensus forecasts for the expected stock price. PRPO (Precipio Inc.)")
The difference between the consensus estimate and the actual stock price PRPO (Precipio Inc.)
Precipio is a diagnostic company that has developed ICE COLD-PCR technology that enables cancer detection using blood samples (liquid biopsy). This chart measures the gap between the current price and the consensus target price. It shows the potential analysts see in this early cancer detection technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PRPO-Precipio-Inc.&v=1772554026676 "A chart showing the difference between the consensus forecast and the actual stock price. PRPO (Precipio Inc.)")
Analyst consensus forecast for stock prices by market segment - Cancer analysis
Precipio (PRPO) is a diagnostic company that developed ICE COLD-PCR technology, which enables highly accurate detection of cancer mutations in blood (liquid biopsy). This chart shows general expectations for the oncology testing sector. It reflects whether experts believe the liquid biopsy market for cancer monitoring will grow.
Analysts' consensus forecast for the overall market share price
Precipio (PRPO) is a company that "improves" cancer diagnostics. They provide technologies and services (HemeScreen) that help pathologists make more accurate diagnoses. This chart shows the general sentiment of experts. It reflects the level of confidence analysts have in the sustainability of healthcare spending in the high-tech diagnostics sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Precipio Inc.
Precipio (PRPO) is a cancer diagnostic specialist. Their business has two pillars: they sell lab services (helping oncologists make diagnoses) and, more importantly, diagnostic kits (HemeScreen), which allow other hospitals to perform these tests in-house. This chart is a summary indicator of their commercialization, reflecting their ability to sell their kits and their struggle to remain profitable.
AKIMA Market Segment Index - Cancer analysis
Precipio (PRPO) is an oncology diagnostics company. They provide blood cancer diagnostic services and own ICE-COLD PCR technology, which improves the accuracy of mutation testing. The chart shows the average index for the segment, helping investors assess the demand for PRPO's diagnostic services compared to the sector average.
The AKIM Index for the overall market
Precipio is a company that provides diagnostic products and services for oncology aimed at reducing errors (HemeScreen). This chart, which reflects the market average, is a backdrop. It helps assess how Precipio, a niche laboratory and test developer, compares to overall macroeconomic trends.
